Izumi Kaji

13PUBLICATIONS
9CO-AUTHORS
Medical infection agents (incl. prions)Tumour immunologyMedical virologyFood properties (incl. characteristics and health benefits)Nutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 30, 2025
LPAR5 as a prospective therapeutic target for treating microvillus inclusion disease.

Andreanna Burman, Izumi Kaji

|Oct 15, 2024
Alterations in cellular metabolic pathway and epithelial cell maturation induced by MYO5B defects are partially reversible by LPAR5 activation.

Michael Momoh, Sudiksha Rathan-Kumar, Andreanna Burman

|Sep 30, 2024
Acute tuft cell ablation induces malabsorption and alterations in secretory and immune cell lineages in small intestine.

Michael Momoh, Francisca Adeniran, Cynthia Ramos

|Sep 16, 2024
Altered cellular metabolic pathway and epithelial cell maturation induced by MYO5B defects are partially reversible by LPAR5 activation.

Michael Momoh, Sudiksha Rathan-Kumar, Andreanna Burman

|Apr 29, 2024
Modeling the cell biology of monogenetic intestinal epithelial disorders.

Izumi Kaji, Jay R Thiagarajah, James R Goldenring

Pageof 3